Found: 34
Select item for more details and to access through your institution.
Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 9, p. 1853, doi. 10.1007/s00432-017-2429-z
- By:
- Publication type:
- Article
<italic>H19</italic> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0486-z
- By:
- Publication type:
- Article
Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 3, p. 659, doi. 10.19746/j.cnki.issn1009-2137.2022.03.002
- By:
- Publication type:
- Article
Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2021, v. 29, n. 5, p. 1436, doi. 10.19746/j.cnki.issn1009-2137.2021.05.011
- By:
- Publication type:
- Article
Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 567, doi. 10.1111/ijlh.13809
- By:
- Publication type:
- Article
Malocclusion Generates Anxiety-Like Behavior Through a Putative Lateral Habenula–Mesencephalic Trigeminal Nucleus Pathway.
- Published in:
- Frontiers in Molecular Neuroscience, 2019, p. 1, doi. 10.3389/fnmol.2019.00174
- By:
- Publication type:
- Article
Methylation‐independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 12, p. 9584, doi. 10.1002/jcp.26866
- By:
- Publication type:
- Article
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
- Published in:
- European Journal of Medical Research, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s40001-022-00899-2
- By:
- Publication type:
- Article
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01373-w
- By:
- Publication type:
- Article
Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.
- Published in:
- BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01193-0
- By:
- Publication type:
- Article
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. 1, doi. 10.1186/s13000-019-0841-1
- By:
- Publication type:
- Article
Changes of Litterfall Amount in Natural Secondary Forests and Chinese Fir Plantations of Different Forest Ages During the Restoration Process.
- Published in:
- Fujian Agricultural Science & Technology, 2022, v. 53, n. 1, p. 59, doi. 10.13651/j.cnki.fjnykj.2022.01.011
- By:
- Publication type:
- Article
ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
- Published in:
- Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00826-9
- By:
- Publication type:
- Article
Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 789, doi. 10.1002/cam4.4905
- By:
- Publication type:
- Article
Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7831, doi. 10.1002/cam4.4284
- By:
- Publication type:
- Article
Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5283, doi. 10.1002/cam4.4085
- By:
- Publication type:
- Article
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6393, doi. 10.1002/cam4.2540
- By:
- Publication type:
- Article
Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 2, p. 1, doi. 10.1002/ctm2.29
- By:
- Publication type:
- Article
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1640, doi. 10.1111/jcmm.14855
- By:
- Publication type:
- Article
Establishment and molecular characterization of decitabine‐resistant K562 cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 5, p. 3317, doi. 10.1111/jcmm.14221
- By:
- Publication type:
- Article
Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.717527
- By:
- Publication type:
- Article
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 11, p. 1, doi. 10.1038/s41419-020-03213-2
- By:
- Publication type:
- Article
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01013-9
- By:
- Publication type:
- Article
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0165948
- By:
- Publication type:
- Article
Decreased <italic>SCIN</italic> expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 6, p. 735, doi. 10.1002/mc.22794
- By:
- Publication type:
- Article
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 9, p. 6604, doi. 10.1002/jcp.26271
- By:
- Publication type:
- Article
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2444, doi. 10.1002/jcp.26119
- By:
- Publication type:
- Article
Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.897898
- By:
- Publication type:
- Article
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4789, doi. 10.2147/OTT.S210168
- By:
- Publication type:
- Article
Comprehensive characterization of TGFB1 across hematological malignancies.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46552-8
- By:
- Publication type:
- Article
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0894-y
- By:
- Publication type:
- Article